📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies (2024)

First Author: King L

Attributed to: Enabling rapid conversion of antigen to vaccine, applied to multi-stage malaria vaccination funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2024.101654

Publication URI: http://dx.doi.org/10.1016/j.xcrm.2024.101654

Type: Journal Article/Review

Parent Publication: Cell Reports Medicine

Issue: 7